Jazz Pharmaceuticals Reports Q3 Financial Results, Raises Full-Year Earnings Guidance
Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a global biopharmaceutical company, announced its financial results Tuesday afternoon for the third quarter of 2021 and updated financial guidance for 2021.
